Directorate Change

TMT Acquisition PLC
26 September 2023
 

 

TMT Acquisition plc

("TMT Acquisition" or the "Company")

Directorate Change

TMT Acquisition (LSE: TMTA), the investment business established to pursue opportunities in the technology, media and telecom sector, is pleased to announce that Paul Tuson will join the Board of TMT Acquisition as a Non-Executive Director with immediate effect.

Paul qualified as a chartered accountant at KPMG, with over twenty years' post-qualification experience, he has served as Chief Financial Officer as well as Non-Executive Director on a number of AIM quoted companies in the media and technology industries. Over this period, he has led successful IPOs, fundraisings and venture capital exits.

Paul served as a Non-Executive Director of AIM quoted financial services company, Harwood Wealth Management Group plc, from March 2016 to April 2020 when it was acquired by Hurst Point Group, now Argentis Group Limited. He was Finance Director and then Chief Financial Officer of Proton Partners International Limited (now Rutherford Health plc), the group committed to providing innovative cancer care to patients and led its IPO on NEX Exchange (now Aquis Exchange) in February 2019. Paul resigned from the Board of Rutherford Health plc in August 2019.

Harry Hyman, Non-Executive Chairman of TMT Acquisition, commented: "It is a pleasure to welcome Paul to the Board of TMT Acquisition. Paul brings with him a wealth of experience from his time spent in both the public and private spheres; he will be a fantastic addition to the Board."

No further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

For further information please contact:

TMT Acquisition plc

Harry Hyman

 

via focusIR

Dowgate Capital Limited - Financial Adviser and Broker

Nicholas Chambers

 

+44 (0)20 3903 7715

focusIR - Investor Relations

Kat Perez

kat.perez@focusir.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings